EJSO-EUR J SURG ONC
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 外科学 Surgery | SCIE | Q1 | 47/321 |
85.4%
|
| 肿瘤学 Oncology | SCIE | Q2 | 142/333 |
57.4%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 外科学 Surgery | SCIE | Q1 | 44/269 JCI 1.22 |
84.0%
|
| 肿瘤学 Oncology | SCIE | Q1 | 45/268 JCI 1.22 |
83.6%
|
EJSO, officially abbreviated as EJSO-EUR J SURG ONC and carrying the ISSN 0748-7983, is a premier, peer-reviewed international journal dedicated to advancing the science and practice of surgical oncology. Published by Elsevier, the journal serves as a vital resource for surgeons, oncologists, clinical researchers, and multidisciplinary cancer care teams. Its scope encompasses the full spectrum of surgical oncology, including the management of solid tumors, innovative surgical techniques, perioperative care, and the integration of surgery with systemic therapies and radiotherapy. EJSO publishes a diverse range of article types, including original research articles, comprehensive reviews, meta-analyses, editorials, and rapid communications, with a strong emphasis on high-quality clinical studies that directly impact patient outcomes. Notable features include options for open access, ensuring broad dissemination of groundbreaking findings, and a rigorous peer-review process that maintains the journal’s high academic standard. With an Impact Factor of 3.5000 (projected for 2026) and a distinguished JCR Quartile ranking of Q1, EJSO stands as a top-tier journal in the field of surgery and oncology. This esteemed position reflects its consistent publication of influential research and its role as a benchmark for clinical excellence and innovation, making it an essential platform for surgeons and researchers seeking to shape the future of cancer treatment.